Nobel laureate Dr. William G. Kaelin Jr. appointed to IQVIA board

IQVIA HOLDINGS INC.

Appointment effective November 5, 2025.
Kaelin awarded 2019 Nobel Prize in Physiology or Medicine for oxygen-sensing and VHL tumor suppressor work.
Senior physician-scientist at Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School.
Also serves on Eli Lilly board and chairs its Science and Technology Committee.
Board determined Kaelin meets NYSE independence standards.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.